家庭醫學科

Medicine & Life Sciences

1. Population 43%
2. Glucose 43%
3. Non-alcoholic Fatty Liver Disease 39%
4. Glucose Intolerance 29%
5. Fasting 29%
6. Sleep 27%
7. Obesity 27%
8. Insulin Resistance 25%
9. Hypertension 24%
10. Blood Pressure 21%
11. Serum 19%
12. Body Mass Index 19%
13. Prediabetic State 18%
14. Students 17%
15. Overweight 17%
16. Body Fat Distribution 17%
17. Diabetes Mellitus 17%
18. Lipids 16%
19. Ankle 16%
20. Arm 16%
21. Prehypertension 16%
22. Elderly 15%
23. alpha-2-HS-Glycoprotein 15%
24. Confidence Intervals 14%
25. Orthostatic Hypotension 14%
26. HDL Cholesterol 14%
27. Exercise 13%
28. Insulin 13%
29. Adipose Tissue 13%
30. Bone Density 13%
31. Streptozocin 13%
32. Regression Analysis 13%
33. Education 12%
34. Cross-Sectional Studies 11%
35. Cardiovascular Diseases 10%
36. Cholesterol 10%
37. Gallstones 10%
38. Logistic Models 10%
39. Uric Acid 10%
40. Odds Ratio 10%
41. Triglycerides 10%
42. Hypoglycemic Agents 10%
43. Magic 10%
44. Smoking 10%
45. Weights and Measures 9%
46. Quality of Life 9%
47. Cohort Studies 8%
48. Transitional Cell Carcinoma 8%
49. Esophagitis 8%
50. Depression 8%
51. Mastication 8%
52. Linear Models 8%
53. Health 7%
54. cardiotrophin 1 7%
55. Glycated Hemoglobin A 7%
56. Chronic Renal Insufficiency 7%
57. Dipeptidyl-Peptidase IV Inhibitors 7%
58. Waist-Hip Ratio 7%
59. Weight Loss 7%
60. Longitudinal Studies 7%
61. Areca 7%
62. Waist Circumference 7%
63. Alleles 7%
64. Randomized Controlled Trials 7%
65. Adiponectin 7%
66. Metformin 7%
67. Neuroticism 7%
68. SARS Virus 7%
69. Stroke 6%
70. Drinking 6%
71. Liver 6%
72. University Hospitals 6%
73. Fibrinogen 6%
74. Smokers 6%
75. Urine 6%
76. Adenoma 6%
77. Baroreflex 6%
78. Kidney 6%
79. Urologic Diseases 6%
80. Outpatients 6%
81. Cost-Benefit Analysis 6%
82. Dioxins 6%
83. Hepatocellular Carcinoma 6%
84. Cysts 6%
85. Neoplasms 6%
86. Costs and Cost Analysis 6%
87. Vaccination 6%
88. Social Support 6%